Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are currently being investigated in trials as potential therapy for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding the ben...

Full description

Saved in:

Bibliographic Details
Published in:	Cochrane database of systematic reviews Vol. 7; p. CD013600
Main Authors:	Piechotta, Vanessa, Chai, Khai Li, Valk, Sarah J, Doree, Carolyn, Monsef, Ina, Wood, Erica M, Lamikanra, Abigail, Kimber, Catherine, McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J, Skoetz, Nicole
Format:	Journal Article
Language:	English
Published:	England 10.07.2020
Subjects:	Betacoronavirus - immunology Cause of Death Coronavirus Infections - immunology Coronavirus Infections - mortality Coronavirus Infections - therapy COVID-19 COVID-19 Serotherapy Early Termination of Clinical Trials Humans Immunization, Passive - adverse effects Immunization, Passive - methods Immunization, Passive - mortality Immunization, Passive - statistics & numerical data Non-Randomized Controlled Trials as Topic - mortality Non-Randomized Controlled Trials as Topic - statistics & numerical data Pandemics Pneumonia, Viral - immunology Pneumonia, Viral - mortality Pneumonia, Viral - therapy Randomized Controlled Trials as Topic - statistics & numerical data Respiration, Artificial - statistics & numerical data SARS-CoV-2 Selection Bias Severity of Illness Index Treatment Outcome
ISSN:	1469-493X, 1469-493X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!